EPBIO (EPBIO) Fair Value & Analysis

IN · Market cap ₹172M

E EPBIO EPBIO · BSE

Price₹102.00

Fair Value₹171.51

Upside+68.1%

Quality56/100

Watch EPBIO for free — get notified when fair value or trend changes. Watch for free

Evidence: High Range ₹106.29 – ₹214.75

Fair value as of: Jul 5, 2026

From 24 valuation models · updated today

Share price +7.4% over the past month.

Price vs Fair Value (12 months)

12‑month range ₹84.00 – ₹149.90 · fair‑value band ₹106.29 – ₹214.75 · the ₹102.00 price screens below the ₹171.51 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

EPBIO (EPBIO) currently trades at ₹102.00, while our model-based Fair Value estimate is ₹171.51 — implying the stock looks roughly 68.1% undervalued today. We read business quality at 56/100 (solid quality). Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

Over the trailing twelve months, EPBIO generated revenue of ₹136M at a net margin of 10.7%. Revenue grew 25.8% year over year. It earns a return on equity of 12.9%. Net debt stands at ₹2.4M. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹106.29 (bear case) to ₹214.75 (bull case); at ₹102.00, the current price sits below that range. The share trades about 32% below its 52-week high and 35% above its 52-week low, currently below its 200-day average.

Key figures & financial health

Revenue (TTM) ₹136M

Revenue growth (YoY) +25.8%

Net margin 10.7%

Return on equity 12.9%

Free cash flow ₹14.0M FY2026

P/E ratio 11.8

More key figures

Operating margin 21.0%

EPS (TTM) ₹8.67

EPS growth (YoY) +64.6%

Net debt ₹2.4M FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

EPBIO reported revenue of ₹136M in FY2026 versus ₹80.6M in FY2022, a compound +14.1%/yr. Reported net income was ₹14.6M in FY2026, compounding +15.9%/yr from FY2022.

Revenue +14.1%/yr

FY22 ₹80.6M

FY23 ₹71.3M

FY24 ₹114M

FY25 ₹120M

FY26 ₹136M

Net income +15.9%/yr

FY22 ₹8.1M

FY23 ₹5.8M

FY24 ₹11.5M

FY25 ₹10.3M

FY26 ₹14.6M

Is EPBIO fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators

DCF Calculator Graham Number Peter Lynch Formula DDM Calculator Fama-French Model Intrinsic Value

📤 Share or link this analysis

𝕏 Post WhatsApp LinkedIn Reddit

🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

EPBIO · Fair Value
₹171.51 +68%Fair Value
Calculator →

<a href="https://www.fairvalue-calculator.com/stock/EPBIO" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:12px;box-sizing:border-box;font-family:system-ui,-apple-system,Segoe UI,Roboto,sans-serif;text-decoration:none;background:#0f1814;color:#eaf2ed;border:1px solid #2a3a30;border-radius:12px;padding:12px 16px;max-width:360px"><span style="line-height:1.35"><span style="font-size:12px;color:#9fb0a8">EPBIO · Fair Value</span><br><b style="font-size:20px">₹171.51</b> <span style="color:#7BB290;font-weight:700;font-size:14px">+68%</span></span><span style="font-size:11px;color:#7BB290;font-weight:700;margin-left:auto;text-align:right;line-height:1.3">Fair&nbsp;Value<br>Calculator&nbsp;→</span></a>

Cite: Fair Value Calculator (2026). "EPBIO Fair Value". https://www.fairvalue-calculator.com/stock/EPBIO

Explore undervalued stocks

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is EPBIO (EPBIO) undervalued?

As of Jul 5, 2026, our model estimates a fair value of ₹171.51 versus a price of ₹102.00 — about +68% (undervalued). Model-based estimate, not financial advice.

What is the fair value of EPBIO?

Our model-based fair value for EPBIO is ₹171.51 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹102.00.

What is the quality score of EPBIO?

EPBIO has a Quality Score of 56/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of EPBIO (EPBIO)?

EPBIO reported trailing-twelve-month revenue of about ₹136M (latest available figure, as of Jul 5, 2026).

What is the net profit margin of EPBIO?

The net profit margin of EPBIO is about 10.7%, meaning it keeps roughly 10.7% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.